
1. influenza respir viruses. 2013 sep;7(5):750-8. doi: 10.1111/irv.12013. epub
2012 sep 24.

advances development universal influenza vaccines.

gilbert sc(1).

author information: 
(1)jenner institute, university oxford, oxford, uk. sarah.gilbert@ndm.ox.ac.uk

despite widespread availability use influenza vaccines, influenza
still poses considerable threat public health. vaccines seasonal
influenza offer protection pandemic viruses, vaccine efficacy 
against seasonal viruses reduced seasons vaccine composition is
not good match predominant circulating viruses. vaccine efficacy is
also reduced older adults, one main target groups for
vaccination. continual threat pandemic influenza, known potential
for rapid spread around world high mortality rates, prompted
researchers develop number novel approaches providing immunity this
virus, focusing target antigens highly conserved different
influenza virus subtypes. several taken clinical
development, review discusses progress made, well
as considering requirements licensing new vaccines they
might used future.

Â© 2012 john wiley & sons ltd.

doi: 10.1111/irv.12013 
pmcid: pmc5781207
pmid: 22998622  [indexed medline]

